Elanco Animal Health Incorporated
ELANFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
4,439
Cost of Revenue
2,530
Gross Profit
1,909
Gross Margin
43.0%
Operating Income
251
Operating Margin
5.7%
Net Income
338
Net Margin
7.6%
EPS (Basic)
$0.68
EPS (Diluted)
$0.68
EBITDA
1,489
EBITDA Margin
33.5%
2023
12/31/2023
Revenue
4,417
Cost of Revenue
2,479
Gross Profit
1,938
Gross Margin
43.9%
Operating Income
326
Operating Margin
7.4%
Net Income
-1,231
Net Margin
-27.9%
EPS (Basic)
$-2.50
EPS (Diluted)
$-2.50
EBITDA
-224
EBITDA Margin
-5.1%
2022
12/31/2022
Revenue
4,411
Cost of Revenue
2,441
Gross Profit
1,970
Gross Margin
44.7%
Operating Income
384
Operating Margin
8.7%
Net Income
-78
Net Margin
-1.8%
EPS (Basic)
$-0.15
EPS (Diluted)
$-0.15
EBITDA
866
EBITDA Margin
19.6%
2021
12/31/2021
Revenue
4,764
Cost of Revenue
2,688
Gross Profit
2,076
Gross Margin
43.6%
Operating Income
304
Operating Margin
6.4%
Net Income
-483
Net Margin
-10.1%
EPS (Basic)
$-0.97
EPS (Diluted)
$-0.97
EBITDA
409
EBITDA Margin
8.6%
2020
12/31/2020
Revenue
3,273
Cost of Revenue
2,027
Gross Profit
1,247
Gross Margin
38.1%
Operating Income
-77
Operating Margin
-2.3%
Net Income
-560
Net Margin
-17.1%
EPS (Basic)
$-1.27
EPS (Diluted)
$-1.27
EBITDA
1
EBITDA Margin
0.0%